Chang and colleagues found that blood concentrations of sP-sel significantly increased after being challenged with venom or anthrax, and pretreatment with sP-Sel (recombinant P-sel IgG-Fc fusion protein) exerted protective effects against coagulopathy and mortality in wild-type mice [18,19]. Here, SELP is linked to blood coagulation disease.